Ionpath

company

About

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$18M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$18M
Ionpath has raised a total of $18M in funding over 2 rounds. Their latest funding was raised on Sep 24, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 24, 2020 Series B $18M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
Ionpath is funded by 3 investors. Paladin Partners Investments and Norwich Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Paladin Partners Investments Series B
Norwich Ventures Series B
Trancos Ventures Series B